HPV prevalence in vulvar cancer in Austria

نویسندگان
چکیده

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Vulvar cancer in Ethiopia

Vulvar cancer (VC) is strongly associated with human papilloma virus (HPV) infections and immunosuppression (e.g., HIV). However, there is limited information on VC patient characteristics and survival in parts of sub-Saharan Africa, including Ethiopia, where chronic HPV and HIV infections are prevalent. The aim of this study is to provide a first view on VC patient characteristics in a sub-Sah...

متن کامل

The Prevalence of HPV Genotypes in Iranian Population: An Update

Background & Objective: Human papillomavirus (HPV) is the main cause of genital warts and some anogenital cancers in male and female subjects which is commonly transmitted by sexual contacts. The objective of this cross-sectional study was to examine the prevalence of HPV genotypes in 10,266 Iranian male and female population, according to their age. Meth...

متن کامل

p14ARF, a prognostic predictor in HPV-negative vulvar carcinoma.

The present study addressed the impact of human papillomavirus (HPV), p14, and the product of the retinoblastoma gene (pRb) in vulvar carcinoma in relation to other clinicopathologic variables and prognosis. We immunohistochemically studied 217 primary tumors from patients with vulvar carcinoma for the expression of pRb and p14. By the use of in situ hybridization, the primary tumors and 7 lymp...

متن کامل

A Very Rare Case: HPV-Negative Vulvar Cancer in an Adolescent

Carcinoma of the vulva is usually regarded as a disease of older women, with the typical age of 65-85 years. There are a limited number of reports of vulvar cancer cases younger than 30 years. These patients have usually risk factors such as human papillomavirus (HPV) infection and immunosuppression. Herein, we present a case of invasive squamous vulvar cancer in an 18-year-old patient without ...

متن کامل

Reduction in HPV prevalence--no evidence to support HPV vaccination reduces HPV prevalence.

world assumptions [9–11]. In particular, a re-analysis of data from 4 randomized clinical trials (RCTs) found that efficacy estimates and confidence intervals for the gold standard RCT analysis and the alternative TND analysis were virtually identical [11]. Other than age, confounding variables have been notably absent in most vaccine effectiveness studies using theTND.Medicationconfoundingmayb...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

ژورنال

عنوان ژورنال: Wiener klinische Wochenschrift

سال: 2017

ISSN: 0043-5325,1613-7671

DOI: 10.1007/s00508-017-1255-2